Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quantified degree of eccentricity of aortic valve calcification predicts risk of paravalvular regurgitation and response to balloon post-dilation after self-expandable transcatheter aortic valve replacement.
Park JB, Hwang IC, Lee W, Han JK, Kim CH, Lee SP, Yang HM, Park EA, Kim HK, Chiam PTL, Kim YJ, Koo BK, Sohn DW, Ahn H, Kang JW, Park SJ, Kim HS. Park JB, et al. Among authors: lee w, lee sp. Int J Cardiol. 2018 May 15;259:60-68. doi: 10.1016/j.ijcard.2017.12.052. Epub 2017 Dec 27. Int J Cardiol. 2018. PMID: 29472027
Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease.
Lee SP, Suh JW, Park KW, Lee HY, Kang HJ, Koo BK, Chae IH, Choi DJ, Rha SW, Bae JW, Cho MC, Kwon TG, Bae JH, Kim HS; CILON-T investigators. Lee SP, et al. Among authors: lee hy. Trials. 2010 Aug 24;11:87. doi: 10.1186/1745-6215-11-87. Trials. 2010. PMID: 20735821 Free PMC article. Clinical Trial.
Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.
Suh JW, Lee SP, Park KW, Lee HY, Kang HJ, Koo BK, Cho YS, Youn TJ, Chae IH, Choi DJ, Rha SW, Bae JH, Kwon TG, Bae JW, Cho MC, Kim HS. Suh JW, et al. Among authors: lee sp, lee hy. J Am Coll Cardiol. 2011 Jan 18;57(3):280-9. doi: 10.1016/j.jacc.2010.08.631. J Am Coll Cardiol. 2011. PMID: 21232664 Free article. Clinical Trial.
Cilostazol attenuates on-treatment platelet reactivity in patients with CYP2C19 loss of function alleles receiving dual antiplatelet therapy: a genetic substudy of the CILON-T randomised controlled trial.
Park KW, Park JJ, Lee SP, Oh IY, Suh JW, Yang HM, Lee HY, Kang HJ, Cho YS, Koo BK, Youn TJ, Chae IH, Choi DJ, Oh BH, Park YB, Kim HS. Park KW, et al. Among authors: lee sp, lee hy. Heart. 2011 Apr;97(8):641-7. doi: 10.1136/hrt.2010.216499. Epub 2011 Feb 22. Heart. 2011. PMID: 21345843 Clinical Trial.
Efficacy of predicting thrombotic events with combination of dual point-of-care testing (POCT) after drug-eluting stent implantation for coronary heart disease: results from the CILON-T randomized trial POCT substudy.
Lee SP, Park KW, Shin DH, Lee HY, Kang HJ, Koo BK, Suh JW, Youn TJ, Choi DJ, Chae IH, Kim HS. Lee SP, et al. Among authors: lee hy. J Atheroscler Thromb. 2011;18(10):914-23. doi: 10.5551/jat.9290. Epub 2011 Jul 26. J Atheroscler Thromb. 2011. PMID: 21791883 Free article. Clinical Trial.
1,132 results